Takeda Pharmaceutical Company Limited (4502.T)
Develops and sells medicines treating rare diseases, cancer, stomach disorders, and other conditions worldwide.
5,847.00+0.02%Healthcare
StockGlow Score
Bullish
BearishBullish
1 year ago+38.7%
The outlook
Takeda trades near the top of its 52-week range and above both its 50- and 200-day averages, reflecting an uptrend. Analysts overwhelmingly favor it with a "Buy" consensus, and their average price target sits roughly 8% above the current level. The overall sentiment is notably bullish based on current market positioning.
What’s behind the score
Analyst consensusBuy — 1.8 avg of 16 analysts
Price trendAbove its 50- & 200-day averages
52-week range90% of the way from its 52-week low to high
Price targetAvg target +8% vs current price
Analyst price target
~12-month · 16 analysts6,318.94average target+8.1% vs now
Now 5,847.00
Low 5,600.00High 7,900.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$9.34T
52-wk high
6,033.00
52-wk low
4,102.00
50-day avg
5,197.20
200-day avg
5,103.91
Trailing P/E
—